Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

about

miR-1307-3p suppresses the chondrogenic differentiation of human adipose-derived stem cells by targeting BMPR2

P2860

Q57071206-939386EB-70B0-4C31-A7A0-72A6510F7F45

P2860

Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

Item

http://www.wikidata.org/entity/Q47111063

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@en

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@nl

type

Item

label

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@en

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@nl

prefLabel

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@en

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@nl

P1476

Rs7911488 modified the efficac ...... R-1307-3p and TYMS expression.

@en

P2093

Dong Hua

http://www.w3.org/2001/XMLSchema#string

Fanyi Meng

http://www.w3.org/2001/XMLSchema#string

Hongjian Zhang

http://www.w3.org/2001/XMLSchema#string

Lei Wang

http://www.w3.org/2001/XMLSchema#string

Qi Chen

http://www.w3.org/2001/XMLSchema#string

Weipeng Wang

http://www.w3.org/2001/XMLSchema#string

Yong Mao

http://www.w3.org/2001/XMLSchema#string

P2860

RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression

Capecitabine in the management of colorectal cancer

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS

Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data.

Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.

A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.

Genetic variation in microRNA networks: the implications for cancer research.

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing

MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells.

P304

74312-74319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19670

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088787

http://www.w3.org/2001/XMLSchema#string

P932

5650342

http://www.w3.org/2001/XMLSchema#string

Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

about

P2860

P2860

Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932